Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Castrate- Resistant Prostate Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Not Yet RecruitingNCT07244393
What this trial is testing

Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Cellbion Co., Ltd. 30
Early research (Phase 1)Study completedNCT01085422
What this trial is testing

A Study Combining ABT-888, Oral PARP Inhibitor, With Temozolomide in Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
AbbVie (prior sponsor, Abbott) 35
Very early researchStudy completedNCT03071328
What this trial is testing

INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological Cancers

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)Metastatic Urothelial CarcinomaMetastatic Renal Cell Carcinoma
Duke University 10
Testing effectiveness (Phase 2)Study completedNCT01942837
What this trial is testing

Study of Enzalutamide in Patients With Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Dana-Farber Cancer Institute 67
Not applicableWithdrawnNCT02905201
What this trial is testing

A Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Ended earlyNCT05256381
What this trial is testing

SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerColorectal CancerCutaneous Squamous Cell Carcinoma+3 more
SOTIO Biotech AG 166
Testing effectiveness (Phase 2)Ended earlyNCT05075577
What this trial is testing

EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPC

Who this might be right for
Prostate Cancer
ESSA Pharmaceuticals 77
Large-scale testing (Phase 3)Study completedNCT05547386
What this trial is testing

68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8
Mayo Clinic 163
Early research (Phase 1)Study completedNCT03737370
What this trial is testing

Fractionated Docetaxel and Radium 223 in Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer
Tufts Medical Center 43
Testing effectiveness (Phase 2)Ended earlyNCT03330405
What this trial is testing

Javelin Parp Medley: Avelumab Plus Talazoparib In Locally Advanced Or Metastatic Solid Tumors

Who this might be right for
Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors
Pfizer 223
Early research (Phase 1)Study completedNCT04477512
What this trial is testing

Cabozantinib and Abiraterone With Checkpoint Inhibitor Immunotherapy in Metastatic Hormone Sensitive Prostate Cancer (CABIOS Trial)

Who this might be right for
Metastatic Hormone Refractory Prostate Cancer
Washington University School of Medicine 18
Testing effectiveness (Phase 2)Study completedNCT03643107
What this trial is testing

Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer Patients
Allarity Therapeutics 15
Large-scale testing (Phase 3)Study completedNCT01193257
What this trial is testing

Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.

Who this might be right for
Prostate Cancer
Millennium Pharmaceuticals, Inc. 1,099
Testing effectiveness (Phase 2)Study completedNCT01807065
What this trial is testing

Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateBone MetastasesHormone-resistant Prostate Cancer+3 more
City of Hope Medical Center 51
Testing effectiveness (Phase 2)Study completedNCT00003400
What this trial is testing

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of Maryland, Baltimore 45
Testing effectiveness (Phase 2)UnknownNCT05327621
What this trial is testing

Pamiparib in mCRPC With HRD or BRCA1/2 Mutation

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Sun Yat-sen University 50
Testing effectiveness (Phase 2)Ended earlyNCT02565901
What this trial is testing

Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IV Prostate Cancer AJCC v7+1 more
University of Washington 28
Testing effectiveness (Phase 2)Ended earlyNCT03177187
What this trial is testing

Combination Study of AZD5069 and Enzalutamide.

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
Institute of Cancer Research, United Kingdom 30
Not applicableStudy completedNCT07477756
What this trial is testing

A Real-world Study of Characteristics, Treatment Patterns, and Clinical Outcomes Among Lutetium-177 Vipivotide Tetraxetan Treated Patients

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals 1,247
Testing effectiveness (Phase 2)UnknownNCT02691975
What this trial is testing

A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients

Who this might be right for
Hormone Refractory Prostate CancerMetastatic Prostate Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 197
Next Page